Bwen Wang

Dr. Bwen Wang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2025 in Advanced Science
Verified
Journal Article
Open access
MPMengjia Peng
Mengjia Peng
JXJianguo Xu
Jianguo Xu
YHYoujian Hong
Youjian Hong
FFFei Fang
Fei Fang
YLYan Li
Yan Li
BWBwen Wang
Bwen Wang
Liver cirrhosis represents a major global health challenge with significant socioeconomic implications. Oxidative stress‐mediated injury plays a pivotal role in driving fibrotic progression, with hepatic macrophages serving as a dominant source of reactive oxygen species (ROS). Consequently, targeted suppression of macrophage‐derived ROS presents a promising therapeutic strategy. Single‐cell RNA sequencing analysis identified Galectin‐3 as positively correlated with macrophage oxidative stress and ROS production. Here, a dynamic DNA nano‐antioxidant (DDN) is developed for hepatic macrophage‐specific small interfering RNA (siRNA) delivery targeting Galectin‐3. DDN administration achieved a 3.92‐fold reduction in Galectin‐3 expression, with transcriptomic profiling revealing restoration of Nuclear Factor Erythroid 2‐Related Factor 2 (NRF2) signaling and consequent attenuation of oxidative stress in macrophages. Pharmacokinetic assessment via IVIS imaging demonstrated superior hepatic accumulation of DDN, exhibiting 1.57‐ and 2.11‐fold greater fluorescence intensity at 240 min post‐injection compared to siRNA and tetrahedral framework nucleic acid (tFNA), respectively. In a carbon tetrachloride (CCl 4 )‐induced mouse model, intraperitoneal DDN administration significantly reduced macrophage oxidative burden, ROS generation, and M1 polarization, ultimately mitigating collagen deposition and fibrotic progression. These findings establish DDN as a potent and targeted therapeutic platform for liver fibrosis treatment.

1 May 2019 in G3: Genes, Genomes, Genetics
Verified
Journal Article
Open access
PDF file
BWBwen Wang
Bwen Wang
ETElizabeth Thompson
Elizabeth Thompson
For heritability estimation using a two-component random effects model, we provided formulas for the limiting distribution of the maximum likelihood estimate. These formulas are applicable even when the wrong measure of kinship is used to capture additive genetic correlation. When the model is correctly specified, we showed that the asymptotic sampling variance of heritability estimate is determined by both the study design and the extent of variation in the kinship measure that constitutes the additive genetic correlation matrix. When the correlation matrix is mis-specified, the extent of asymptotic bias depends additionally on how the fitted correlation matrix differs from the truth. In particular, we showed in a simulation study that estimating heritability using a population-based design and the classic GRM as the fitted correlation matrix can potentially contribute to the ”missing heritability” problem.

27 September 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
YXYeyang Xu
Yeyang Xu
TWTeng Wang
Teng Wang
JZJiajia Zeng
Jiajia Zeng
BWBwen Wang
Bwen Wang
LZLiqing Zhou
Liqing Zhou
NZNasha Zhang
Nasha Zhang
Transarterial chemoembolization (TACE) has significantly prolonged overall survival (OS) of unresectable hepatocellular carcinoma (HCC) patients. Unfortunately, there are still a portion of patients without therapeutic responses to TACE. Although genome-wide association studies identified multiple HCC susceptibility SNPs, it is still largely unclear how genome-wide identified functional SNPs impacting gene expression contribute to the prognosis of TACE-treated HCC patients. In this study, we developed an integrative functional genomics methodology to identify gene expression-related SNPs significantly contributing to prognosis of TACE-treated HCC patients across the whole genome. Employing integration of data from expression quantitative trait locus (eQTLs) analyses of The Cancer Genome Atlas (TCGA) liver hepatocellular carcinoma (LIHC) as well as the 1000 Genomes project, we successfully annotated 60 gene expression-related SNPs which are associated with OS of the TCGA patients. After genotyping these 60 SNPs in our TACE cohort, we identified four SNPs (rs12574873, rs12513391, rs34597395, and rs35624901) which are significantly associated with OS of HCC patients treated with TACE. For instance, multivariate Cox proportional hazards model indicated that the rs35624901 Deletion.Deletion (Del.Del) genotype carriers had markedly prolonged OS and a 55% decreased death risk compared with individuals with the GG genotype after TACE therapy (p = 8.3 × 10–5). In support of this, the rs35624901 Del.Del genotype is correlated to higher expression of RAG1, a key T-/B-cell deficiency regulator. Our findings reported the first evidence supporting the prognostic value of four eQTL SNPs in TACE-treated HCC patients. Importantly, our data implicated that antitumor immunity might contribute to TACE efficiency for unresectable HCC patients.

1 September 2024 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
BWBwen Wang
Bwen Wang
MPMengjia Peng
Mengjia Peng
LJLiheng Jiang
Liheng Jiang
FFFei Fang
Fei Fang
JWJuan Wang
Juan Wang
YWYuliang Wang
Yuliang Wang
Wang, Bowen, Mengjia Peng,, Liheng Jiang,, Fei Fang,, Juan Wang,, Yan Li,, Ruichen Zhao,, and Yuliang Wang,. A Rare Case of High-Altitude Polycythemia Complicated by Spontaneous Splenic Rupture. High Alt Med Biol. 25:247–250, 2024.—High-altitude polycythemia, a condition characterized by an increase in red blood cellRBC mass, can occur after prolonged exposure to high altitudes. While several studies have explored the complications associated with high-altitude polycythemia, there is currently no literature available on spontaneous spleen rupture caused by high-altitude polycythemia. Here, we reported a case of acute abdominal pain and hemodynamic instability in a 36-year-old male who had been residing at high altitude for 6 years, without any recent history of trauma. Computed tomography imaging revealed significant fluid accumulation in the abdomen, and a tear of the splenic capsule was identified during the following laparotomy. Subsequent evaluations confirmed the presence of polycythemia secondary to prolonged high-altitude exposure as the underlying etiology. This case served as an important reminder that high-altitude polycythemia could lead to serious complications, such as spontaneous spleen rupture. Clinicians should be aware of this potential complication and consider it in the differential diagnosis of patients presenting with abdominal pain and hemodynamic instability in this population.

16 September 2026 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
BWBwen Wang
Bwen Wang
MPMengjia Peng
Mengjia Peng
JOJunjie Ouyang
Junjie Ouyang
YLYangyang Liu
Yangyang Liu
YHYoujian Hong
Youjian Hong
YWYuliang Wang
Yuliang Wang
Background: Acute respiratory distress syndrome (ARDS) and pancreatitis are fatal extrahepatic complication of hepatitis E virus (HEV)–induced acute liver failure (ALF). High-altitude hypobaric hypoxia may exacerbate pulmonary endothelial injury and delay tissue repair, but its impact on the severity and reversibility of ALF-related pancreatitis and ARDS remain uncharacterized. Case presentation: A 44-year-old male (Body mass index 31.7 kg/m 2 ) presented with jaundice, oliguria and progressive hypoxemic respiratory failure 1 month after rapid ascent from 1,190 m to 3,650 m. He was diagnosed with HEV-associated ALF, severe refractory ARDS, stage 3 acute kidney injury (AKI) and concurrent severe acute pancreatitis. Despite lung-protective ventilation, neuromuscular blockade and daily prone positioning, hypoxemia remained refractory at high altitude. The patient also received continuous renal replacement therapy and artificial liver support with dual plasma molecular adsorption system plus double filtration plasmapheresis. After 17 days, his condition stabilized but ARDS and AKI recovery was delayed. Following transfer to a hospital at 500 m altitude, oxygenation, liver and kidney function improved significantly within 3 weeks. Conclusion: Sustained high-altitude hypoxia may contribute to refractoriness and delayed recovery of ALF-related ARDS. Altitude descent may be a valuable adjuvant strategy for hemodynamically stable patients with refractory hypoxemia, pending further prospective validation.

1 October 2015 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
XSXudong Shi
Xudong Shi
KWKatie Wang
Katie Wang
LGLiang-Wang Guo
Liang-Wang Guo
BWBwen Wang
Bwen Wang
MZMengxue Zhang
Mengxue Zhang
CKCraig K. Kent
Craig K. Kent